Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion, Malignant × Valacyclovir × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 Gynecologic 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Trastuzumab 2 tipifarnib 1 Valacyclovir 1 Thoracentesis 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01997190 2023-08-25

MpeTK01

Candel Therapeutics, Inc.

Phase 1 Completed

BreastGynecologicOther solid neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Mesothelioma, Ovarian Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡